Abstract

The goal is to compare and contrast the anaesthetic effects of otolaryngology surgery using cisatracurium besylate and mivacurium chloride. For a retrospective analysis, 108 patients who underwent ENT surgery in our hospital between November 2021 and March 2022 were selected. Patients in the experimental group A were given cisatracurium besylate, while patients in the experimental group B were given mivacurium. The anaesthetic effects and recovery of the two groups were then compared and analysed. At the six time periods of admission, anaesthetic induction, intubation, end of procedure, recovery of consciousness, and extubation, there was no statistically significant difference in mean arterial pressure, heart rate, or pulse oximetry levels between the two groups.

Extubation, recuperation after surgery, and the train of four stimulation levels were all considerably greater than they were for experimental group A. The experimental group B experienced much shorter recovery times for self-consciousness, extubation, and eye opening than the experimental group A, and experienced significantly less agitation than the experimental group A. The overall incidence of unfavourable conditions was substantially lower in experimental group B than it was in experimental group A. Mivacurium chloride anaesthesia presents a viable alternative to cisatracurium besylate in otolaryngology surgery in terms of reduced hemodynamic impact, quicker postoperative recovery, lack of the build-up of neuromuscular blockade, less unpleasant responses, and higher safety.